TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 100nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 190nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 1.25E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 4.20E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 4.46E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 4.50E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 4.70E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 4.91E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 5.54E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 5.70E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 5.80E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 5.80E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 5.80E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 6.11E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 7.97E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 9.27E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 9.30E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 1.20E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 1.30E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 1.40E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 1.40E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 1.50E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 1.70E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 1.70E+4nMAssay Description:Inhibition of PHD2 in HEK293 cells assessed as VEGF release by immunoassayMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 1.90E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 2.10E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: >3.00E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: >3.00E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: >3.00E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: >3.00E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: >3.00E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 7.90E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair